Leading Lights of Electrochemistry Assemble at October 240th ECS Meeting

ECS is proud to announce that the 240th ECS Meeting will take place at the Orange County Convention Center in Orlando, FL, from October 10-14, 2021. The Electrochemistry in Space Symposium is a highlight of the meeting, among other events. Learn more!

Read more

WashU Experts: The first 100 Biden/Harris days

Obamacare will get retooled, not repealed. A national mask mandate will boost consumer spending, research shows (though don’t expect much from homeowners, they’re strapped). The $300 billion for R&D should go to D, not R. So forecasts an array of WashU experts.

Read more

Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2

Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection. MAbs are human-made proteins meant to mimic human immune system antibodies. Texas Biomed Professors Luis Martinez-Sobrido, Ph.D. and Jordi B. Torrelles, Ph.D. will co-lead the project to evaluate the protective efficacy of these MAbs in small rodent models, developed at Texas Biomed, on behalf of the Coronavirus Immunotherapy Consortium (CoVIC), an international nonprofit consortium evaluating MAb therapeutics for COVID-19.

Read more

Baylor Scott & White Health announces new affiliations with Baylor College of Medicine and Texas A&M University to further expand the pipeline of exceptional clinical talent for Texas

Baylor Scott & White Health, the largest not-for-profit health system in the state of Texas, today announces two separate academic affiliations: a new affiliation with Baylor College of Medicine and an expanded affiliation with their long-time partner Texas A&M University. Both alliances are aimed at training future clinicians and developing programs that advance high-quality care and healthcare innovation.

Read more

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.

Read more

‘Artificial Chemist’ Combines AI, Robotics to Conduct Autonomous R&D

Researchers have developed a technology called “Artificial Chemist,” which incorporates artificial intelligence and an automated system for performing chemical reactions to accelerate R&D and manufacturing of commercially desirable materials.

Read more

Modelling confirms: Isolating the ill and prioritising remote work are key strategies in combating the coronavirus

This release concerns conclusive results from a research project that was put together to model the potential spread of coronavirus through air particles in indoor public spaces such as supermarkets (https://www.aalto.fi/en/news/researchers-modelling-the-spread-of-the-coronavirus-emphasise-the-importance-of-avoiding-busy)

Read more